South Korea
· Delayed Price · Currency is KRW Novomics Statistics
Total Valuation
Novomics has a market cap or net worth of KRW 4.11 billion. The enterprise value is 5.56 billion.
| Market Cap | 4.11B |
| Enterprise Value | 5.56B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Novomics has 6.53 million shares outstanding.
| Shares Outstanding | 6.53M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 37.62% |
| Owned by Institutions (%) | 4.29% |
| Float | 3.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 19.97 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.63 |
| EV / Sales | 27.00 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.25 |
Financial Position
The company has a current ratio of 3.09
| Current Ratio | 3.09 |
| Quick Ratio | 2.94 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.71 |
| Interest Coverage | -13.00 |
Financial Efficiency
Return on equity (ROE) is -1,403.46% and return on invested capital (ROIC) is -97.73%.
| Return on Equity (ROE) | -1,403.46% |
| Return on Assets (ROA) | -43.27% |
| Return on Capital (ROIC) | -97.73% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.03 |
| Inventory Turnover | 2.32 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novomics had revenue of KRW 206.03 million and -3.42 billion in losses. Loss per share was -523.33.
| Revenue | 206.03M |
| Gross Profit | 45.13M |
| Operating Income | -5.30B |
| Pretax Income | -3.42B |
| Net Income | -3.42B |
| EBITDA | -4.60B |
| EBIT | -5.30B |
| Loss Per Share | -523.33 |
Balance Sheet
The company has 1.72 billion in cash and 3.17 billion in debt, giving a net cash position of -1.45 billion or -221.80 per share.
| Cash & Cash Equivalents | 1.72B |
| Total Debt | 3.17B |
| Net Cash | -1.45B |
| Net Cash Per Share | -221.80 |
| Equity (Book Value) | -1.44B |
| Book Value Per Share | -220.01 |
| Working Capital | 1.34B |
Cash Flow
In the last 12 months, operating cash flow was -4.45 billion and capital expenditures -1.49 million, giving a free cash flow of -4.45 billion.
| Operating Cash Flow | -4.45B |
| Capital Expenditures | -1.49M |
| Free Cash Flow | -4.45B |
| FCF Per Share | -681.64 |
Margins
| Gross Margin | 21.91% |
| Operating Margin | -2,574.77% |
| Pretax Margin | -1,659.01% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -2,160.91% |
Dividends & Yields
Novomics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -142.67% |
| Shareholder Yield | -142.67% |
| Earnings Yield | -83.07% |
| FCF Yield | -108.20% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |